Longboard Pharmaceuticals Inc (LBPH) Quarterly Balance Sheets

Quarterly · GAAP · USD millions
Access LBPH Annual Balance Sheets →
The data below summarizes Longboard Pharmaceuticals Inc's balance sheet position from Sep 30 2023 to Sep 30 2024, enabling a period-by-period comparison of financial strength.
Quarterly Report, GAAP in USD millions
ITEM
(Sep 30 2024)
(Jun 30 2024) (Mar 31 2024) (Dec 31 2023) (Sep 30 2023)
Assets
Cash & cash equivalent27.61
Short-term Investments, Total260.84
Cash & Short-term Investments287.00
Prepaid Expense And Other Assets Current4.58
Total Current Assets293.03
Equipment/Property/Plant Net0.00
Long-term investments0.24
Other Assets, Noncurrent3.98
Operating Lease Right Of Use Asset3.73
Total Assets297.01
Liabilities
Accounts Payable, Current AC1.13
Accrued Liabilities, Current AC1.89
Other Liabilities, Current15.33
Total Current Liabilities18.35
Total Long-term Debt0.00
Accrued Research And Development Expenses10.90
Total Liabilities21.82
Stockholders' Equity
Common Stock Value0.00
Additional Paid In Capital Common Stock476.36
Retained Earnings / Accumulated Deficit-201.88
Other Equity0.70
Common Stockholder's Equity275.19
Total Stockholder's Equity275.19
Liabilities & Stockholder's Equity297.01
4 historic quarters locked

Sign in to unlock the full Longboard Pharmaceuticals Inc balance sheet history.

About Longboard Pharmaceuticals Inc Quarterly Balance Sheet

What this statement shows

This page presents issuer-reported balance sheet data, detailing assets, liabilities, and stockholders equity as reported in SEC 10-Q filings and standardized by CSIMarket. The balance sheet reflects the company's financial position at the end of each reporting period.

Source & verification

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - balance-sheet normalization in the CSIMarket.com financial database.
  • Accession: 0000950170-24-123341

Balance sheet figures represent financial position at specific reporting dates and may be revised in subsequent filings.